B Fisher

Summary

Affiliation: National Surgical Adjuvant Breast and Bowel Project
Country: USA

Publications

  1. ncbi Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    J Clin Oncol 19:931-42. 2001
  2. ncbi From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, 4 Allegheny Center, Pittsburgh, Pennsylvania 15212 5234, USA
    Eur J Cancer 35:1963-73. 1999
  3. ncbi Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Division of Pathology, and Breast Committee, Pittsburgh, PA, USA
    J Clin Oncol 20:4141-9. 2002
  4. ncbi Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
    B Fisher
    B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA, USA
    J Natl Cancer Inst 93:112-20. 2001
  5. ncbi Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    J Clin Oncol 17:3374-88. 1999
  6. ncbi Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    N Engl J Med 347:567-75. 2002
  7. ncbi Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    N Engl J Med 347:1233-41. 2002
  8. ncbi Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
    Bernard Fisher
    Operations Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA
    Lancet 364:858-68. 2004
  9. ncbi Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, and Department of Surgery, University of Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 93:684-90. 2001
  10. ncbi Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Operations Center, USA
    J Natl Cancer Inst 96:1823-31. 2004

Detail Information

Publications33

  1. ncbi Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    J Clin Oncol 19:931-42. 2001
    ....
  2. ncbi From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, 4 Allegheny Center, Pittsburgh, Pennsylvania 15212 5234, USA
    Eur J Cancer 35:1963-73. 1999
    ..Perhaps the most important accomplishment of the twentieth century relates to the change in the pro..
  3. ncbi Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Division of Pathology, and Breast Committee, Pittsburgh, PA, USA
    J Clin Oncol 20:4141-9. 2002
    ....
  4. ncbi Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
    B Fisher
    B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA, USA
    J Natl Cancer Inst 93:112-20. 2001
    ....
  5. ncbi Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    J Clin Oncol 17:3374-88. 1999
    ..B-25 was initiated to determine whether further intensifying and increasing the cyclophosphamide dose would yield more favorable results...
  6. ncbi Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    N Engl J Med 347:567-75. 2002
    ..We report 25-year findings of a randomized trial initiated in 1971 to determine whether less extensive surgery with or without radiation therapy was as effective as the Halsted radical mastectomy...
  7. ncbi Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    N Engl J Med 347:1233-41. 2002
    ..In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as effective as total mastectomy for the treatment of invasive breast cancer...
  8. ncbi Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials
    Bernard Fisher
    Operations Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA
    Lancet 364:858-68. 2004
    ..We present long-term findings from those trials and relate them to age, menopausal status, and tumour oestrogen-receptor concentrations. We also discuss the extent of progress made in the treatment of such patients...
  9. ncbi Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, and Department of Surgery, University of Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 93:684-90. 2001
    ....
  10. ncbi Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials
    Bernard Fisher
    National Surgical Adjuvant Breast and Bowel Project, Operations Center, USA
    J Natl Cancer Inst 96:1823-31. 2004
    ..This report presents updated findings from those trials, relates the results to age and menopausal status, and estimates the extent of progress made in treating such patients...
  11. ncbi Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project Scientific Director s Office, Pittsburgh, PA 15261, USA
    J Clin Oncol 14:1982-92. 1996
    ....
  12. ncbi Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18
    B Fisher
    Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Shadyside Hospital, PA, USA
    J Clin Oncol 15:2483-93. 1997
    ..To determine whether preoperative doxorubicin and cyclophosphamide (AC) permits more lumpectomies to be performed and decreases the incidence of positive nodes in women with primary breast cancer...
  13. ncbi Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA, USA
    J Clin Oncol 16:2672-85. 1998
    ....
  14. ncbi Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01
    N Wolmark
    University of Pittsburgh, PA
    J Natl Cancer Inst 80:30-6. 1988
    ....
  15. ncbi Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01
    B Fisher
    University of Pittsburgh, PA
    J Natl Cancer Inst 80:21-9. 1988
    ..The observed advantage was restricted to males. Postoperative radiation therapy reduced the incidence of local-regional recurrence, but it failed to affect overall disease-free survival and survival...
  16. ncbi Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212 5234, USA
    Lancet 353:1993-2000. 1999
    ..We did a double-blind randomised controlled trial to find out whether lumpectomy, radiation therapy, and tamoxifen was of more benefit than lumpectomy and radiation therapy alone for DCIS...
  17. ncbi erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
    S Paik
    National Surgical Adjuvant Breast and Bowel Project, Department of Human Oncology, Allegheny University of Health Sciences, Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 90:1361-70. 1998
    ..Overexpression of the erbB-2 protein by breast cancer cells has been suggested to be a predictor of response to doxorubicin. A retrospective study was designed to test this hypothesis...
  18. ncbi Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast
    N Wolmark
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 17:3553-9. 1999
    ..To compare the efficacy of leucovorin-modulated fluorouracil (FU+LV) with that of fluorouracil and levamisole (FU+LEV) or with the combination of FU+LV and levamisole (FU+LV+LEV)...
  19. ncbi Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA, USA
    Semin Oncol 28:400-18. 2001
    ..It does suggest, however, that, in the treatment of DCIS, the appropriate use of current and better therapeutic agents that become available could diminish the significance of breast cancer as a public health problem...
  20. ncbi Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06
    E R Fisher
    National Surgical Adjuvant Breast and Bowel Project Pathology Center, Pittsburgh, Pennsylvania, USA
    Cancer 91:1679-87. 2001
    ....
  21. ncbi Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 90:1371-88. 1998
    ..To test this hypothesis, the National Surgical Adjuvant Breast and Bowel Project initiated the Breast Cancer Prevention Trial (P-1) in 1992...
  22. ncbi Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
    N Wolmark
    N Wolmark, D L Wickerham, E R Fisher, B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP Operations Center, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst 92:388-96. 2000
    ..This study was carried out to address this issue. An additional aim was to determine whether leucovorin (LV)-modulated 5-fluorouracil (5-FU) is superior to the combination of 5-FU, semustine, and vincristine (MOF) in men...
  23. ncbi Long-term tamoxifen citrate use and potential ocular toxicity
    M B Gorin
    Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pennsylvania 15213, USA
    Am J Ophthalmol 125:493-501. 1998
    ..To estimate the prevalence of abnormalities in visual function and ocular structures associated with the long-term use of tamoxifen citrate...
  24. ncbi S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer
    J Bryant
    NSABP, University of Pittsburgh, PA 15213, USA
    Breast Cancer Res Treat 51:239-53. 1998
    ..The diversity of risk in the B-14 population was more extreme than is generally recognized. The prognostic capabilities of S-phase, tumor size, and PgR status were sharply attenuated as the time from surgery increased...
  25. ncbi Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    M C King
    University of Washington, Seattle, WA 98195, USA
    JAMA 286:2251-6. 2001
    ..The effect of tamoxifen on breast cancer incidence among women at extremely high risk due to inherited BRCA1 or BRCA2 mutations is unknown...
  26. ncbi The dose-volume interaction in adult supratentorial low-grade glioma: higher radiation dose is beneficial among patients with partial resection
    C Leighton
    Division of Radiation Oncology, London Regional Cancer Centre Program, London Health Sciences Hospital, and Department of Medical Oncology, University of Western Ontario, London, Ontario, Canada
    J Neurooncol 82:165-70. 2007
    ..To evaluate the hypothesis that adults with partially resected (PR<50% resection) supratentorial low-grade glioma (LGG) benefit from higher doses of radiation...
  27. ncbi A National Cancer Institute of Canada Clinical Trials Group Study--IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer
    J A Maroun
    Medical Oncology, The Ottawa Hospital Regional Cancer Centre, 501 Smyth Road, Ottawa, Ont, Canada K1H 8L6
    Eur J Cancer 42:193-9. 2006
    ..3%) experienced partial response. Further evaluation in a randomized study compared to sequential doublets is warranted. Triple combinations could be relevant in curative settings for high-risk patients...
  28. ncbi Helical tomotherapy for craniospinal radiation
    G Bauman
    Department of Radiation Oncology, London Regional Cancer Centre, Ontario, Canada
    Br J Radiol 78:548-52. 2005
    ..On the basis of this case study, further evaluation of HT for craniospinal radiotherapy seems justified...
  29. ncbi Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group
    C M Canil
    Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Ave, Toronto, Ontario M5G 2M9, Canada
    J Clin Oncol 23:455-60. 2005
    ....
  30. ncbi Preoperative (neoadjuvant) chemotherapy in patients with breast cancer
    E P Mamounas
    Department of Surgery, Case Western Reserve University and Aultman Cancer Center, Canton, OH 44710, USA
    Semin Oncol 28:389-99. 2001
    ..The potential advantages and disadvantages of each approach, as well as surgical considerations and current and future directions in the use of preoperative chemotherapy, are also discussed...
  31. ncbi Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial
    W Roa
    Cross Cancer Institute, 11560 University Ave, Edmonton, Alberta, Canada T6G 1Z2
    J Clin Oncol 22:1583-8. 2004
    ..To prospectively compare standard radiation therapy (RT) with an abbreviated course of RT in older patients with glioblastoma multiforme (GBM)...
  32. ncbi A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers
    M J MacKenzie
    Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada
    Ann Oncol 15:665-70. 2004
    ..This phase I trial was conducted to determine the recommended doses of these agents, and their pharmacokinetic properties and toxicities in patients with advanced solid malignancies...
  33. doi Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    Anushka Patel
    N Engl J Med 358:2560-72. 2008
    ..In patients with type 2 diabetes, the effects of intensive glucose control on vascular outcomes remain uncertain...